Previous studies have shown that higher levels of FoxP3+Treg cells indicate a poor prognosis in cancer patients, but this idea has recently been challenged to suggest that high levels of tumor-infiltrating FoxP3+Treg cells are not always associated with poor prognosis but can improve survival time in some types of tumors [15, 16]. This evidence concerns the gene FOXP3 and neoplasm.